Last mentioned: Apr 17, 2026
Strategic Target
Deadline for China to become the primary global exporter of medical technology standards.
Leadership Mandate
New policy shift explicitly targets global leadership over 'catching up' with Western tech.
Patent Milestone
China surpasses the US in total international patent filings for CRISPR and AI-drug discovery.
14th Five-Year Plan
China emphasizes 'self-reliance' and domestic technology loops.
China’s latest strategic roadmap shifts from a 'catch-up' posture to a mandate for global leadership in frontier technologies. This pivot places biotechnology and genomic medicine at the center of national security and economic growth, challenging decades of U.S. dominance in drug innovation.
This page surfaces every story mentioning United States across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where United States was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |